Bringing research from bench to bedside.
Science Report 2024
New interim co-scientific directors
We are pleased to introduce the new interim co-scientific and managing directors of our research institute: Eleni Tomazou and Sabine Taschner-Mandl. With their extensive expertise and many years of experience as Researchers and Principal Investigators, they are taking over the management of the Institute on a temporary basis. Both stand for continuity and innovation and will support the Institute with commitment and vision.
“Our priority is to safeguard the excellent research work of the Institute and to further promote the exchange within the scientific community,” says Eleni Tomazou. Sabine Taschner-Mandl adds: “We look forward to actively shaping this transitional phase together with our dedicated team.”
Our Mission
St. Anna Children’s Cancer Research Institute (CCRI) strives to improve treatment for children and adolescents with cancer by bringing together translational and clinical research with open-minded exploration of basic disease mechanisms. Every year, 250-300 children and adolescents in Austria alone are diagnosed with cancer. Thanks to research, more than 80 % of these children will now survive. Integrally connected with St. Anna Children’s Hospital, experimental and theoretical scientists at CCRI work side-by-side with oncologists to tackle eminent issues in pediatric cancer research and therapy.
The CCRI trains a generation of passionate and courageous researchers thriving on this interdisciplinary exchange and it hosts state-of-the-art experimental facilities to power this mission. CCRI tears down conventional boundaries by constant exchange and collaboration with outside institutions in order to go the extra mile for the benefit of the patient. Bringing research from bench to bedside, CCRI headquarters multiple clinical trials and is tightly integrated in international networks to maximize innovation and impact.
Highlights
150
15
37
110
News
New Project: Zinc Finger Proteins
30 Percent Relapse Rate in Childhood AML: Researcher Seeks New Weak Points in Blood Cancer…
Neuroblastoma: New combination method reliably detects hidden tumor cells
Neuroblastoma: New combination method reliably detects hidden tumor cells (Vienna, 04.09.2025) – Hidden tumor cells in…
Bridging to clinical translation: Professor Kaan Boztug honored for his research on personalized medicine approaches…
IGF-1 as the “Ignition Key” for Bone Cancer: Vienna-Based Research Team Unravels Origins of Ewing…